THURSDAY, Jan. 25 (HealthDay News) -- Betadine use may not increase the rate of deflation of saline breast implants and, with proper use, could help to reduce the incidence of capsular contracture, a Texas surgeon reports in the January issue of Plastic and Reconstructive Surgery.
Thomas Wiener, M.D., a plastic surgeon in Houston, Texas, reviewed his own use of Betadine in breast augmentation surgeries conducted in 1,244 patients between 1998 and 2005, to measure the rates of implant deflation and capsular contracture. The U.S. Food and Drug Administration banned Betadine use for breast augmentation in 2000 because of reports of implant deflation associated with its use.
Wiener found that his deflation rate was 0.24 percent, significantly lower than the 7 percent to 10 percent deflation rate reported by the FDA. In addition, the capsular contracture rate was lower than the FDA reports (0.5 percent to 2.2 percent versus 10 to 11 percent, respectively).
"This article confirms other studies reporting that the use of Betadine has no effect on the rate of deflation of a saline breast implant," Wiener writes. "It also shows that the incidence of capsular contracture is significantly decreased with the proper use of Betadine." The author notes that his recommendations were endorsed by the Texas Society of Plastic Surgeons in 2005.
Abstract
Full Text (subscription or payment may be required)
